Home > National Drug Code (NDC) > LANEIGE SATIN FINISH TWIN PACT NO. 23

LANEIGE SATIN FINISH TWIN PACT NO. 23 - 43419-865-42 - (TITANIUM DIOXIDE, OCTINOXATE, and ZINC OXIDE)

Alphabetical Index


Drug Information of LANEIGE SATIN FINISH TWIN PACT NO. 23

Product NDC: 43419-865
Proprietary Name: LANEIGE SATIN FINISH TWIN PACT NO. 23
Non Proprietary Name: TITANIUM DIOXIDE, OCTINOXATE, and ZINC OXIDE
Active Ingredient(s): .06; .08; .0294    mg/g; mg/g; mg/g & nbsp;   TITANIUM DIOXIDE, OCTINOXATE, and ZINC OXIDE
Administration Route(s): TOPICAL
Dosage Form(s): POWDER
Coding System: National Drug Codes(NDC)

Labeler Information of LANEIGE SATIN FINISH TWIN PACT NO. 23

Product NDC: 43419-865
Labeler Name: AMOREPACIFIC
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20101201

Package Information of LANEIGE SATIN FINISH TWIN PACT NO. 23

Package NDC: 43419-865-42
Package Description: 13 g in 1 CONTAINER (43419-865-42)

NDC Information of LANEIGE SATIN FINISH TWIN PACT NO. 23

NDC Code 43419-865-42
Proprietary Name LANEIGE SATIN FINISH TWIN PACT NO. 23
Package Description 13 g in 1 CONTAINER (43419-865-42)
Product NDC 43419-865
Product Type Name HUMAN OTC DRUG
Non Proprietary Name TITANIUM DIOXIDE, OCTINOXATE, and ZINC OXIDE
Dosage Form Name POWDER
Route Name TOPICAL
Start Marketing Date 20101201
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name AMOREPACIFIC
Substance Name OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE
Strength Number .06; .08; .0294
Strength Unit mg/g; mg/g; mg/g
Pharmaceutical Classes

Complete Information of LANEIGE SATIN FINISH TWIN PACT NO. 23


General Information